Drug
Peramivir clinical trials
Also written Rapivab.
- studies test it
- 15
- open now
- 1
- in phase 3
- 8
- first study started
- 2006
Keep track of what changes. Save the peramivir studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2015 (3)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 3 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 6
- Phase 3
- 8
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 5
BioCryst Pharmaceuticals (10) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Johns Hopkins University (1) · Chinese University of Hong Kong (1) · University of Oxford (1)
Often tested with
Tested in the same studies.
Oseltamivir (3) · Favipiravir (1) · Zanamivir (1) · Baloxavir (1) · Molnupiravir (1) · Laninamivir (1)
Studies
Open first, then newest update. How each study uses peramivir is read from its arms, and is right about nine times in ten.
Testing it · 15
- A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic InfluenzaRecruitingPhase 2University of OxfordNCT05648448Written as Peramivir
- A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.WithdrawnPhase 3BioCryst PharmaceuticalsNCT01224795Written as Peramivir
- Intramuscular Peramivir for the Treatment of Uncomplicated InfluenzaWithdrawnPhase 3BioCryst PharmaceuticalsNCT00486980Written as Peramivir 150mg
- Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated InfluenzaCompletedPhase 3BioCryst PharmaceuticalsNCT02635724Written as Peramivir
- Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated InfluenzaCompletedPhase 3BioCryst PharmaceuticalsNCT02369159Written as Peramivir
- Intramuscular Peramivir in Subjects With Uncomplicated Acute InfluenzaTerminatedPhase 3BioCryst PharmaceuticalsNCT00610935Written as Peramivir
- ED Influenza Therapeutic Pilot Study: Oseltamivir vs. PeramivirCompletedPhase 4Johns Hopkins UniversityNCT02609399Written as Peramivir
- Safety and Dose Study of Peramivir for Influenza TreatmentCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00297050Written as Peramivir
- Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract InfectionsCompletedPhase 2/3Chinese University of Hong KongNCT02665351Written as Peramivir
- A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute InfluenzaCompletedPhase 2BioCryst PharmaceuticalsNCT00705406Written as Peramivir
- Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.CompletedPhase 2BioCryst PharmaceuticalsNCT00419263Written as Peramivir 150 mg
- Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected InfluenzaCompletedPhase 3BioCryst PharmaceuticalsNCT00957996Written as Peramivir
- Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening InfluenzaCompletedPhase 2BioCryst PharmaceuticalsNCT00453999Written as Peramivir 200 mg
- A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to InfluenzaTerminatedPhase 3BioCryst PharmaceuticalsNCT00958776Written as Peramivir+SOC
- Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With InfluenzaWithdrawnPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT01063933Written as Peramivir
Codes
What other systems call peramivir · ClinicalTrials.gg INT004271
- MeSH (NLM) C414210peramivirConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) QW7Y7ZR15UPERAMIVIRConfirmed FDA, NLM, Wikidata
- RxNorm 619693Confirmed FDA, Wikidata
- Wikidata Q47495829peramivir trihydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81611PeramivirConfirmed FDA, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C414210 | peramivir | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | QW7Y7ZR15U | PERAMIVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 619693 | — | Confirmed FDA, Wikidata |
| Wikidata | Q47495829 | peramivir trihydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81611 | Peramivir | Confirmed FDA, Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.